InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the detailed record of transactions filed by Butler John P., Chairman & CEO. Officer active across 2 companies, notably Zynerba Pharmaceuticals, Inc.. In total, 6 disclosures have been published. Total volume traded: €48k. The latest transaction was disclosed on 14 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
023,109 shares0
Common Stock
SEC:0001062993-22-015037:0·
€48,28225,053 shares@ €1.92720.017% mcap100.0% of flow
Common Stock
SEC:0001562180-22-002166:0·
1,248 shares
Common Stock
SEC:0001562180-22-001654:0·
1,248 shares
Common Stock
SEC:0001562180-22-001654·
05,000 shares0
Common Stock
SEC:0001192482-21-000646·
05,000 shares0
Common Stock
SEC:0001192482-21-000646:0·
6 of 6 declarations
About Butler John P.
John P. Butler is the CEO and President of Zynerba Pharmaceuticals, Inc. and Akebia Therapeutics, Inc. He leads these companies with an innovation-driven approach in the biopharmaceutical field. John is committed to developing treatments that address unmet patient needs.
